EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinical and Analytical Validation of Two Methods for Ki-67 Scoring in Formalin Fixed and Paraffin Embedded Tissue Sections of Early Breast Cancer

Snežana Đokić, Barbara Gazić, Biljana Grčar Kuzmanov, Jerca Blazina, Simona Miceska iD, Tanja Čugura, Cvetka Grašič Kuhar iD, Jera Jeruc iD

Cancers · 03.04.2024 · 16 (7) · 1405

DOI: 10.3390/cancers16071405 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 03.04.2024. Verfasst von Snežana Đokić und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Institute of Oncology, 1000 Ljubljana, Slovenia. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Slovenian Research Agency.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Proliferation determined by Ki-67 immunohistochemistry has been proposed as a useful prognostic and predictive marker in breast cancer. However, the clinical validity of Ki-67 is questionable. In this study, Ki-67 was retrospectively evaluated by three pathologists using two methods: a visual assessment of the entire slide and a quantitative assessment of the tumour margin in 411 early-stage breast cancer patients with a median follow-up of 26.8 years. We found excellent agreement between the three pathologists for both methods. The risk of recurrence for Ki-67 was time-dependent, as the high proliferation group (Ki-67 ≥ 30%) had a higher risk of recurrence initially, but after 4.5 years the risk was higher in the low proliferation group. In estrogen receptor (ER)-positive patients, the intermediate Ki-67 group initially followed the high Ki-67 group, but eventually followed the low Ki-67 group. ER-positive pN0-1 patients with intermediate Ki-67 treated with endocrine therapy alone had a similar outcome to patients treated with chemotherapy. A cut-off value of 20% appeared to be most appropriate for distinguishing between the high and low Ki-67 groups. To summarize, a simple visual whole slide Ki-67 assessment turned out to be a reliable method for clinical decision-making in early breast cancer patients. We confirmed Ki-67 as an important prognostic and predictive biomarker.

Schlagwörter

Stichwörter der Autor:innen

Ki-67MIB-1S-phase fractionbreast cancerimmunohistochemistryproliferation

Autor:innen und Institutionen

  • Department of Pathology, Institute of Oncology, 1000 Ljubljana, Slovenia.
  • Faculty of Medicine Ljubljana, University of Ljubljana, 1000 Ljubljana, Slovenia.
  • Department of Cytopathology, Institute of Oncology, 1000 Ljubljana, Slovenia.
  • Institute of Pathology, Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia.
  • Department of Medical Oncology, Institute of Oncology Ljubljana, 1000 Ljubljana, Slovenia.

ORCID-Profile: Simona Miceska, Cvetka Grašič Kuhar, Jera Jeruc

Förderung

  • Slovenian Research Agency

Zitieren

APA

Đokić, S., Gazić, B., Grčar Kuzmanov, B., Blazina, J., Miceska, S., Čugura, T., Grašič Kuhar, C., & Jeruc, J. (2024). Clinical and Analytical Validation of Two Methods for Ki-67 Scoring in Formalin Fixed and Paraffin Embedded Tissue Sections of Early Breast Cancer. Cancers, 16(7), 1405. https://doi.org/10.3390/cancers16071405

Vancouver

Đokić S, Gazić B, Grčar Kuzmanov B, Blazina J, Miceska S, Čugura T, et al. Clinical and Analytical Validation of Two Methods for Ki-67 Scoring in Formalin Fixed and Paraffin Embedded Tissue Sections of Early Breast Cancer. Cancers. 2024;16(7):1405. doi:10.3390/cancers16071405

BibTeX
@article{oki2024,
  author = {Đokić, Snežana and Gazić, Barbara and Grčar Kuzmanov, Biljana and Blazina, Jerca and Miceska, Simona and Čugura, Tanja and Grašič Kuhar, Cvetka and Jeruc, Jera},
  title = {Clinical and Analytical Validation of Two Methods for Ki-67 Scoring in Formalin Fixed and Paraffin Embedded Tissue Sections of Early Breast Cancer},
  journal = {Cancers},
  year = {2024},
  volume = {16},
  number = {7},
  pages = {1405},
  doi = {10.3390/cancers16071405}
}
Kostenlos starten →